April 19, 2013
Pharmaceuticals manufacturer Shire PLC has settled its patent infringement claims against Sandoz Inc. over the company's attempt to develop a generic form of Intuniv, an attention deficit hyperactivity disorder drug, according to an order issued Thursday by a Colorado federal judge.
April 29, 2011
Shire LLC filed a patent infringement suit against Sandoz Inc. on Wednesday in Colorado over the generics maker's bid to produce a version of attention deficit hyperactivity disorder drug Intuniv.